Psyence Biomedical (PBM) news
Recent news
Psyence Biomedic - TIRC and PsyLabs to conclude definitive agreement by November 30, 2026
Psyence Biomedical Ltd. (Nasdaq: PBM) announced that its wholly-owned subsidiary, Texas Ibogaine Research Corporation (TIRC), has entered into a binding term sheet with Psyence Labs Ltd. (PsyLabs) for an exclusive U.S. license arrangement . The term sheet is binding and must be replaced by a…
AInvest Wire · Oct 5, 2026PSYence Biomedical Ltd: Partners with DEA-registered Benuvia operations to establish U.S. manufacture of pharmaceutical-grade ibogaine
Psyence Biomedical Ltd. (Nasdaq: PBM) has taken a significant step in its U.S. development strategy by forming Texas Ibogaine Research Corporation (TIRC), a dedicated subsidiary to coordinate the regulated development of ibogaine in the United States. TIRC is intended to serve as the primary…
AInvest Wire · Oct 5, 2026Psyence Biomedical - Definitive agreement for exclusive U.S. ibogaine license expected by November 30, 2026
AInvest Wire · Sep 28, 2026Psyence Biomedical - Post-deal, PsyLabs to hold 49.89% of Psyence Biomed, Psyence Biomed 41.13% of PsyLabs
Psyence Biomedical Ltd. (Nasdaq: PBM) has finalized the acquisition of Psyence Group’s 11.13% stake in PsyLabs, a privately held psychedelic API development company, marking a significant step in its vertical integration strategy. Following the transaction, PsyLabs now holds a 49.89% stake in…
AInvest Wire · Sep 23, 2026Psyence Biomedical - Co and Psy Labs agree to $9 mln value-matched share exchange
Psyence Biomedical Ltd. (Nasdaq: PBM) and PsyLabs have agreed to a value-matched share exchange valued at $9 million, as part of a strategic equity investment and put option agreement. Under the terms of the transaction, PsyLabs will issue 2,900 shares to Psyence Biomedical, representing a fair…
AInvest Wire · Sep 23, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.